首页> 外文期刊>respiration >Protective Effect of Ketotifen and Disodium Cromoglycate Against Bronchoconstriction Induced by Aspirin, Benzoic Acid or Tartrazine in Intolerant Asthmatics
【24h】

Protective Effect of Ketotifen and Disodium Cromoglycate Against Bronchoconstriction Induced by Aspirin, Benzoic Acid or Tartrazine in Intolerant Asthmatics

机译:酮替芬和色甘酸二钠对阿司匹林、苯甲酸或柠檬黄引起的支气管收缩对不耐受哮喘患者的保护作用

获取原文
获取外文期刊封面目录资料

摘要

Oral challenge tests with acetylsalicylic acid, tartrazine or benzoic acid were performed in 7 intolerant asthmatic patients after a 3-day treatment with either orally taken ketotifen (1 mg twice daily) or inhaled disodium cromoglycate (20 mg four times daily) at random. Protection was noted with ketotifen in 5, with DSCG in 3 patients. On the evaluation of the mean percentage of the maximum decline in the forced expiratory volume in 1 sec (FEV1 only ketotifen afforded significant protection statistically (p α1-antitrypsin serum values were under the lower normal range
机译:对 7 名不耐受哮喘患者进行乙酰水杨酸、柠檬黄碱或苯甲酸口服挑战试验,接受口服酮替芬(1 mg,每日两次)或吸入色甘酸二钠(20 mg,每日 4 次)治疗 3 天。5例患者使用酮替芬起到保护作用,3例患者使用DSCG起到保护作用。在评估 1 秒内用力呼气容积最大下降的平均百分比时(FEV1 仅酮替芬在统计学上提供了显着的保护 (p < 0.05)。所有不耐受的哮喘研究都显示,作为一种免疫异常,Q抑制剂水平略有但显着下降。此外,其中3例的α1-抗胰蛋白酶血清值低于正常值下限

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号